Back to results
US 9,434,988 B2Granted
RNase H-based assays utilizing modified RNA monomers
AssigneeIntegrated Dna Technologies, Inc.
InventorsMark Aaron Behlke, Scott D. Rose, Joseph Dobosy, Joseph Alan Walder
Life of this patent
Estimating the term…
Abstract
The present invention provides methods of cleaving a nucleic acid strand to initiate, assist, monitor or perform biological assays.
Claims11
A method of amplifying a target DNA sequence, the method comprising the steps of:
- (a) providing a reaction mixture at a starting temperature at or below 40° C. wherein the reaction mixture comprises:
- (i) a first oligonucleotide primer having a cleavage domain positioned 5′ of a blocking group, the blocking group linked at or near the end of the 3′-end of the oligonucleotide primer, wherein the blocking group prevents primer extension and/or PCR,
- (ii) a sample nucleic acid that may or may not have the target sequence,
- (iii) a cleaving enzyme, wherein the cleaving enzyme is an RNase H2 enzyme,
- (iv) a polymerase, and
- (v) optionally, a second oligonucleotide primer in reverse orientation to support PCR;
- (b) elevating the temperature of the reaction mixture to at or above 50° C. to increase the activity of the RNase H2 enzyme;
- (c) hybridizing the blocked oligonucleotide primer to the target DNA sequence to form a double-stranded substrate;
- (d) cleaving the hybridized oligonucleotide primer with the cleaving enzyme at a point within or adjacent to the cleavage domain to remove the blocking group from the oligonucleotide primer;
- and
- (e) extending the oligonucleotide primer with the polymerase,
- wherein the RNase H2 enzyme has, at the starting temperature, less than about 16% of the activity that the RNase H2 enzyme has at the elevated temperature in step (b).
9 more elements
Dependencies are inferred from the claim text.